**Question:** Which of the following anti-asthma drugs is not indicated by oral route of administration in pregnancy -

A. Salbutamol
B. Fluticasone
C. Leukotriene modifiers
D. Montelukast

**Correct Answer:** **D. Montelukast:**

**Core Concept:** Asthma management during pregnancy involves careful selection of drugs that are safe for both the mother and the fetus. In this context, we will discuss four commonly used anti-asthma drugs and their suitability for oral administration during pregnancy.

**Why the Correct Answer is Right:** Montelukast (D) is a selective leukotriene receptor antagonist that is effective in controlling asthma symptoms. However, it is not considered the first-line therapy for asthma in pregnancy due to limited data on its safety profile.

**Why Each Wrong Option is Incorrect:**

**A. Salbutamol:** Salbutamol is a short-acting beta-2 agonist used for rapid relief of asthma symptoms. Although it is generally considered safe during pregnancy, its regular use for long periods may lead to adrenal suppression, which is a concern in pregnancy.

**B. Fluticasone:** Fluticasone is a corticosteroid with anti-inflammatory properties that is commonly used for asthma control. Its safety during pregnancy is well established, making it a suitable choice for oral administration.

**C. Leukotriene modifiers:** As mentioned earlier, leukotriene modifiers like montelukast (D) are not the first-line therapy for asthma management in pregnancy due to limited safety data. Leukotriene modifiers like zafirlukast and zileuton are also not recommended due to similar concerns regarding safety during pregnancy.

**Clinical Pearl:** When selecting asthma medications for pregnant patients, it is essential to consider the drug's safety profile and evidence-based data on the risks and benefits in this specific population. In most cases, corticosteroids like fluticasone are preferred over leukotriene modifiers like montelukast due to limited data on their safety during pregnancy.

**Core Concept:** The choice of asthma medications during pregnancy is guided by the drug's safety profile and the available evidence regarding its risks and benefits in this vulnerable population. In most instances, corticosteroids like fluticasone are favored over leukotriene modifiers like montelukast due to limited data on their safety during pregnancy.